http://120.24.161.253:5617/index.php?action=history&feed=atom&title=%E8%82%9D%E7%97%85-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-INR
肝病-实验室检查-INR - 版本历史
2026-05-05T06:13:05Z
本wiki的该页面的版本历史
MediaWiki 1.30.0
http://120.24.161.253:5617/index.php?title=%E8%82%9D%E7%97%85-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-INR&diff=1409386&oldid=prev
Admin：修改1
2024-07-06T14:00:00Z
<p>修改1</p>
<table class="diff diff-contentalign-left" data-mw="interface">
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 14:00的版本</td>
</tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div>
</td></tr></table>
Admin
http://120.24.161.253:5617/index.php?title=%E8%82%9D%E7%97%85-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-INR&diff=1409387&oldid=prev
KGadmin：导入1个版本
2024-07-06T10:01:17Z
<p>导入1个版本</p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 10:01的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7" >第7行：</td>
<td colspan="2" class="diff-lineno">第7行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===RIPK3介导肝细胞程序性坏死在乙型肝炎相关慢加急性肝衰竭中的作用（中华医学会文献）===</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===RIPK3介导肝细胞程序性坏死在乙型肝炎相关慢加急性肝衰竭中的作用（中华医学会文献）===</div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>所有[[肝病]]患者血清中 RIPK3水平与 ALT(r= 0.5804,P<del class="diffchange diffchange-inline">< </del>0.0001)、AST(r= 0.8114,P<del class="diffchange diffchange-inline"><</del>0.0001)、总胆红素(r=0.5388,P<del class="diffchange diffchange-inline"><</del>0.0001)、PT(r=0.5690,P<del class="diffchange diffchange-inline"><</del>0.0001)和[[INR]](r=0.5724,P</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>所有[[肝病]]患者血清中 RIPK3水平与 ALT(r= 0.5804,P<ins class="diffchange diffchange-inline">&amp;lt; </ins>0.0001)、AST(r= 0.8114,P<ins class="diffchange diffchange-inline">&amp;lt;</ins>0.0001)、总胆红素(r=0.5388,P<ins class="diffchange diffchange-inline">&amp;lt;</ins>0.0001)、PT(r=0.5690,P<ins class="diffchange diffchange-inline">&amp;lt;</ins>0.0001)和[[INR]](r=0.5724,P</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">===儿童遗传代谢性肝病的实验室诊断（中华医学会文献）===</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">根据欧洲[[肝病]]学会发布的临床指南，胆红素、AST、白蛋白、[[INR]]和白细胞计数可作为预后判断的指标［11］。</ins></div></td></tr>
</table>
KGadmin
http://120.24.161.253:5617/index.php?title=%E8%82%9D%E7%97%85-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-INR&diff=498896&oldid=prev
Admin：导入1个版本
2021-10-21T08:25:41Z
<p>导入1个版本</p>
<table class="diff diff-contentalign-left" data-mw="interface">
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="1" style="background-color: white; color:black; text-align: center;">2021年10月21日 (四) 08:25的版本</td>
</tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div>
</td></tr></table>
Admin
http://120.24.161.253:5617/index.php?title=%E8%82%9D%E7%97%85-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-INR&diff=498893&oldid=prev
Admin：修改1
2021-10-19T13:56:59Z
<p>修改1</p>
<p><b>新页面</b></p><div>主实体：[[肝病]]，关系：[[实验室检查]] ，尾实体：[[INR]]<br />
<br />
实体ID:''9524097''<br />
==关系介绍==<br />
待补充<br />
<br />
==来源==<br />
===RIPK3介导肝细胞程序性坏死在乙型肝炎相关慢加急性肝衰竭中的作用（中华医学会文献）===<br />
所有[[肝病]]患者血清中 RIPK3水平与 ALT(r= 0.5804,P< 0.0001)、AST(r= 0.8114,P<0.0001)、总胆红素(r=0.5388,P<0.0001)、PT(r=0.5690,P<0.0001)和[[INR]](r=0.5724,P</div>
Admin